Kyle C. Garrison

Digital biomarkers are objective, quantifiable physiological and behavioral data collected through digital devices such as smartphones, wearable sensors, and connected medical tools. Unlike traditional biomarkers, which often rely on laboratory tests or in-clinic measurements, digital biomarkers are generated continuously in real-world settings. They capture signals like heart rhythm, physical activity, sleep patterns, voice characteristics, typing behavior, and movement dynamics, transforming everyday interactions with technology into health insights.From Episodic Care to Continuous MonitoringConventional health checkups usually occur sporadically through infrequent clinic appointments and brief diagnostic evaluations, while digital biomarkers move this approach toward ongoing monitoring. Around-the-clock tracking from wearable devices can…

Zero-knowledge proofs, or ZKPs, first emerged within academic cryptography and later entered the public spotlight through blockchain technology and privacy-driven cryptocurrencies. Their fundamental appeal lies in a remarkable idea: a party can verify the truth of a claim without disclosing the data that substantiates it. As organizations confront increasing demands to safeguard confidential information, meet rigorous regulatory requirements, and still operate collaboratively across different entities, this approach is becoming valuable well beyond digital asset ecosystems.A hands-on perspective on zero-knowledge proofsAt an enterprise level, ZKPs enable verifiable trust with minimal disclosure. Instead of sharing raw data, organizations can share proofs that…